Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2005
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/20/2005US6977255 8-Substituted 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-ones inhibitor of phosphoinositide (PI) 3- kinase, an enzyme that regulates platelet-adhesion (antithrombotic agent)
12/20/2005US6977254 For prevention and/or suppression of preterm labor, suppression labor at term prior to caesarean deliver, and for the treatment of dysmenorrhea, useful in enhancing fertility rates
12/20/2005US6977252 Use of 1,4-benzothiazepine derivatives as drugs for overcoming resistance to anticancer drugs
12/20/2005US6977246 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
12/20/2005US6977244 Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/20/2005US6977150 Process and compositions for peptide, protein and peptidomimetic synthesis
12/20/2005US6977076 Immunomoderators; high molecular weight polysaccharides
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005CA2329703C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/20/2005CA2328903C Compounds capable of cleaving double-stranded dna and method of utilization of the same
12/20/2005CA2324324C Treatment of pulmonary hypertension
12/20/2005CA2092896C Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
12/15/2005WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer
12/15/2005WO2005118631A1 Novel protein complex and use thereof
12/15/2005WO2005118629A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
12/15/2005WO2005118588A1 Fused heterocyclic compound
12/15/2005WO2005118582A1 Corneal perception recovery drug containing amide compound
12/15/2005WO2005118556A1 Propane-1,3-dione derivative or its salt
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005118009A2 Transdermal delivery system for treatment of cognitive disorders
12/15/2005WO2005117886A1 Adhesive patch
12/15/2005WO2005070459A8 Method of continuing expression of vector repeatedly administered
12/15/2005US20050277773 Pyrrolopyrimidine derivatives
12/15/2005US20050277691 Pravastatin pharmaceutical formulations and methods of their use
12/15/2005US20050277683 Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
12/15/2005US20050277660 Novel tetrahydroquinoline derivatives
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005US20050277618 Methods
12/15/2005US20050277617 Comprises an amino sugar and trehalose
12/15/2005US20050277614 Methods for modulating the axonal outgrowth of central nervous system neurons
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277603 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
12/15/2005US20050277583 Histone deacetylase inhibitors and process for producing the same
12/15/2005US20050277573 Disinfectant
12/15/2005US20050277108 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050276789 Immunostimulatory oligonucleotides and uses thereof
12/15/2005US20050276755 Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate
12/15/2005CA2568524A1 Modulators of muscarinic receptors
12/15/2005CA2567655A1 Binding moieties based on shark ignar domains
12/14/2005EP1604993A1 Inhibitors
12/14/2005EP1604984A1 Water-soluble phenylpyridazine derivative and medicine containing the same
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604981A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/14/2005EP1604686A1 Use of phenserine and a HMG CoA reductase inhibitor for delaying Alzheimer's disease progression
12/14/2005EP1604673A1 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method
12/14/2005EP1604671A1 Muscle-building agent and preventive or remedy for muscle weakening
12/14/2005EP1604665A1 C-kit kinase inhibitor
12/14/2005EP1604664A1 Medicine for prevention of and treatment for arteriosclerosis and hypertension
12/14/2005EP1604663A1 Zolpidem Hemitartrate Form H Solvate
12/14/2005EP1604651A1 Transdermal patches and methods for delivering testosterone
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1527084A4 Promoters exhibiting endothelial cell specificity and methods of using same
12/14/2005EP1509228B1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
12/14/2005EP1496902B1 Medicament containing steroids and a novel anticholinergic drug
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1438410B1 Promoters to control cell differentiation
12/14/2005EP1438290B1 Cyclohept b!indole derivatives as spla2 inhibitors
12/14/2005EP1427709B1 3-substituted-4-pyrimidone derivatives
12/14/2005EP1280904B1 Pain signaling molecules
12/14/2005EP1274430B1 Cabergoline for the treatment of fibromyalgia and chronic fatigue syndrome
12/14/2005EP1267803B1 Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1255870B1 5-hydroxytryptamine transporter gene polymorphisms
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005EP1217989B1 Vaccines for oral use which contain liposome-entrapped dna
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005EP1007047B1 Use of mizolastine for preparing a medicine for treating inflammation
12/14/2005EP0956036B1 Anti-fibrotic agent assay
12/14/2005CN1708540A High-molecular weight derivatives of camptothecins
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1708311A Remedy for fibromyalgia
12/14/2005CN1708295A Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
12/14/2005CN1706838A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/14/2005CN1231762C Method for directly identifying candidate compound
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231479C Naphthostyrils compounds
12/14/2005CN1231473C Substituted arylpyrazines
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231466C New piperidine derivatives
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/14/2005CN1231459C Novel aminobenzophenones
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/14/2005CN1231262C Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising the same
12/14/2005CN1231256C Non-aqueous proton peptide formulations
12/14/2005CN1231245C Chinese medicine capable of making cultured prawn quickly shelling and disinfecting water thereof
12/14/2005CN1231239C Medicine for curing hydrocephalus, brain abscess and brain tumor and preparation process thereof
12/14/2005CN1231232C Lotion for improving immunity of human body
12/14/2005CN1231218C Use of medicinal composition in preparing medicine for treating middle ear infections
12/14/2005CN1231215C (Imidazol-5-yl) methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
12/13/2005US6974867 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974831 sPLA2 inhibitors
1 ... 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 ... 1564